Assay ID | Title | Year | Journal | Article |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID504812 | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID1745845 | Primary qHTS for Inhibitors of ATXN expression | | | |
AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | | | |
AID504810 | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
AID567047 | DPPH radical scavenging activity assessed as reducing ability at 0.2 mM after 20 mins | 2011 | European journal of medicinal chemistry, Jan, Volume: 46, Issue:1
| Design, synthesis and pharmacobiological evaluation of novel acrylic acid derivatives acting as lipoxygenase and cyclooxygenase-1 inhibitors with antioxidant and anti-inflammatory activities. |
AID567040 | Antioxidant activity assessed as Fe3+/ascorbic acid-induced hydroxyl radical scavenging activity at 0.01 mM | 2011 | European journal of medicinal chemistry, Jan, Volume: 46, Issue:1
| Design, synthesis and pharmacobiological evaluation of novel acrylic acid derivatives acting as lipoxygenase and cyclooxygenase-1 inhibitors with antioxidant and anti-inflammatory activities. |
AID567048 | DPPH radical scavenging activity assessed as reducing ability at 0.2 mM after 60 mins | 2011 | European journal of medicinal chemistry, Jan, Volume: 46, Issue:1
| Design, synthesis and pharmacobiological evaluation of novel acrylic acid derivatives acting as lipoxygenase and cyclooxygenase-1 inhibitors with antioxidant and anti-inflammatory activities. |
AID567042 | Antioxidant activity assessed as Fe3+/ascorbic acid-induced superoxide anion radical scavenging activity at 0.1 mM | 2011 | European journal of medicinal chemistry, Jan, Volume: 46, Issue:1
| Design, synthesis and pharmacobiological evaluation of novel acrylic acid derivatives acting as lipoxygenase and cyclooxygenase-1 inhibitors with antioxidant and anti-inflammatory activities. |
AID567038 | Inhibition of soybean LOX | 2011 | European journal of medicinal chemistry, Jan, Volume: 46, Issue:1
| Design, synthesis and pharmacobiological evaluation of novel acrylic acid derivatives acting as lipoxygenase and cyclooxygenase-1 inhibitors with antioxidant and anti-inflammatory activities. |
AID567041 | Antioxidant activity assessed as Fe3+/ascorbic acid-induced hydroxyl radical scavenging activity at 0.1 mM | 2011 | European journal of medicinal chemistry, Jan, Volume: 46, Issue:1
| Design, synthesis and pharmacobiological evaluation of novel acrylic acid derivatives acting as lipoxygenase and cyclooxygenase-1 inhibitors with antioxidant and anti-inflammatory activities. |
AID567045 | DPPH radical scavenging activity assessed as reducing ability at 0.1 mM after 20 mins | 2011 | European journal of medicinal chemistry, Jan, Volume: 46, Issue:1
| Design, synthesis and pharmacobiological evaluation of novel acrylic acid derivatives acting as lipoxygenase and cyclooxygenase-1 inhibitors with antioxidant and anti-inflammatory activities. |
AID567050 | Antioxidant activity assessed as reduction of ABTS radical at 0.1 mM | 2011 | European journal of medicinal chemistry, Jan, Volume: 46, Issue:1
| Design, synthesis and pharmacobiological evaluation of novel acrylic acid derivatives acting as lipoxygenase and cyclooxygenase-1 inhibitors with antioxidant and anti-inflammatory activities. |
AID567046 | DPPH radical scavenging activity assessed as reducing ability at 0.1 mM after 60 mins | 2011 | European journal of medicinal chemistry, Jan, Volume: 46, Issue:1
| Design, synthesis and pharmacobiological evaluation of novel acrylic acid derivatives acting as lipoxygenase and cyclooxygenase-1 inhibitors with antioxidant and anti-inflammatory activities. |
AID567051 | Antioxidant activity assessed as inhibition of linoleic acid peroxidation at 0.1 mM by AAPH assay | 2011 | European journal of medicinal chemistry, Jan, Volume: 46, Issue:1
| Design, synthesis and pharmacobiological evaluation of novel acrylic acid derivatives acting as lipoxygenase and cyclooxygenase-1 inhibitors with antioxidant and anti-inflammatory activities. |
AID567043 | DPPH radical scavenging activity assessed as reducing ability at 0.05 mM after 20 mins | 2011 | European journal of medicinal chemistry, Jan, Volume: 46, Issue:1
| Design, synthesis and pharmacobiological evaluation of novel acrylic acid derivatives acting as lipoxygenase and cyclooxygenase-1 inhibitors with antioxidant and anti-inflammatory activities. |
AID567037 | Antiinflammatory activity in Fisher 344 rat assessed as inhibition of carrageenan-induced paw oedema at 0.01 mmol/kg, ip | 2011 | European journal of medicinal chemistry, Jan, Volume: 46, Issue:1
| Design, synthesis and pharmacobiological evaluation of novel acrylic acid derivatives acting as lipoxygenase and cyclooxygenase-1 inhibitors with antioxidant and anti-inflammatory activities. |
AID567049 | Antioxidant activity assessed as inhibition of heme protein-dependent lipid peroxidation at 1 mM | 2011 | European journal of medicinal chemistry, Jan, Volume: 46, Issue:1
| Design, synthesis and pharmacobiological evaluation of novel acrylic acid derivatives acting as lipoxygenase and cyclooxygenase-1 inhibitors with antioxidant and anti-inflammatory activities. |
AID567039 | Inhibition of COX1 at 100 uM | 2011 | European journal of medicinal chemistry, Jan, Volume: 46, Issue:1
| Design, synthesis and pharmacobiological evaluation of novel acrylic acid derivatives acting as lipoxygenase and cyclooxygenase-1 inhibitors with antioxidant and anti-inflammatory activities. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |